Erdheim-Chester Disease
- 1 May 2013
- journal article
- review article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 39 (2), 299-311
- https://doi.org/10.1016/j.rdc.2013.02.011
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- Pulmonary involvement in Erdheim‐Chester disease: A single‐center study of thirty‐four patients and a review of the literatureArthritis & Rheumatism, 2010
- Recurrent BRAF mutations in Langerhans cell histiocytosisBlood, 2010
- Erdheim-Chester Disease Presenting as Bilateral Clinically Malignant Breast MassesThe American Journal of Surgical Pathology, 2010
- Erdheim-Chester Disease in ChildhoodJournal of Pediatric Hematology/Oncology, 2009
- Imatinib mesylate for platelet-derived growth factor receptor-beta–positive Erdheim-Chester histiocytosisBlood, 2008
- Erdheim-Chester disease: case report with multisystemic manifestations including testes, thyroid, and lymph nodes, and a review of literatureJournal of Clinical Pathology, 2004
- Erdheim–Chester diseaseAustralasian Journal of Dermatology, 2003
- Coexistence of localized Langerhans cell histiocytosis and cutaneous Rosai-Dorfman diseaseBritish Journal of Dermatology, 2002
- Mutations of the BRAF gene in human cancerNature, 2002